iBio, Inc. (IBIO)
NASDAQ: IBIO · Real-Time Price · USD
1.200
-0.080 (-6.25%)
At close: Dec 5, 2025, 4:00 PM EST
1.200
0.00 (0.02%)
After-hours: Dec 5, 2025, 7:52 PM EST
iBio, Inc. Stock Forecast
Stock Price Forecast
The 4 analysts with 12-month price forecasts for iBio, Inc. stock have an average target of 4.50, with a low estimate of 2.00 and a high estimate of 6.00. The average target predicts an increase of 275.00% from the current stock price of 1.20.
Analyst Consensus: Strong Buy
* Price targets were last updated on Oct 21, 2025.
Analyst Ratings
The average analyst rating for iBio, Inc. stock from 4 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 | Dec '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 2 | 2 | 2 |
| Buy | 0 | 0 | 0 | 2 | 2 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 4 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Oppenheimer | Oppenheimer | Buy Initiates $5 | Buy | Initiates | $5 | +316.67% | Oct 21, 2025 |
| Leerink Partners | Leerink Partners | Buy Initiates $2 | Buy | Initiates | $2 | +66.67% | Oct 17, 2025 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $5 | Strong Buy | Maintains | $5 | +316.67% | Jun 25, 2025 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $5 | Strong Buy | Maintains | $5 | +316.67% | May 6, 2025 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $5 | Strong Buy | Maintains | $5 | +316.67% | May 5, 2025 |
Financial Forecast
Revenue This Year
153.00K
from 400.00K
Decreased by -61.75%
Revenue Next Year
170.00K
from 153.00K
Increased by 11.11%
EPS This Year
-0.44
from -1.75
EPS Next Year
-0.30
from -0.44
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 525,000 | 525,000 | |||
| Avg | 153,000 | 170,003 | |||
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 31.3% | 243.1% | |||
| Avg | -61.8% | 11.1% | |||
| Low | - | - |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | -0.29 | -0.19 | |||
| Avg | -0.44 | -0.30 | |||
| Low | -0.80 | -0.37 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.